CA3067188A1 - Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess - Google Patents

Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess Download PDF

Info

Publication number
CA3067188A1
CA3067188A1 CA3067188A CA3067188A CA3067188A1 CA 3067188 A1 CA3067188 A1 CA 3067188A1 CA 3067188 A CA3067188 A CA 3067188A CA 3067188 A CA3067188 A CA 3067188A CA 3067188 A1 CA3067188 A1 CA 3067188A1
Authority
CA
Canada
Prior art keywords
genus
bacteria belonging
bacteria
lung
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3067188A
Other languages
English (en)
French (fr)
Inventor
Masaaki Odajima
Sayoko Tanioka
Takaaki Sunouchi
Asako Tabuchi
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority claimed from PCT/JP2018/022846 external-priority patent/WO2018230686A1/ja
Publication of CA3067188A1 publication Critical patent/CA3067188A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA3067188A 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess Abandoned CA3067188A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762520961P 2017-06-16 2017-06-16
US62/520,961 2017-06-16
JP2018068159 2018-03-30
JP2018-068159 2018-03-30
PCT/JP2018/022846 WO2018230686A1 (ja) 2017-06-16 2018-06-15 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤

Publications (1)

Publication Number Publication Date
CA3067188A1 true CA3067188A1 (en) 2018-12-20

Family

ID=66213244

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3067188A Abandoned CA3067188A1 (en) 2017-06-16 2018-06-15 Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess

Country Status (14)

Country Link
US (1) US20210137913A1 (https=)
EP (1) EP3639826A4 (https=)
JP (3) JP6618660B2 (https=)
KR (1) KR20200016960A (https=)
CN (1) CN110891571A (https=)
AU (1) AU2018283234A1 (https=)
BR (1) BR112019025960A2 (https=)
CA (1) CA3067188A1 (https=)
CL (1) CL2019003630A1 (https=)
IL (1) IL270831A (https=)
MX (1) MX2019014931A (https=)
PH (1) PH12019502835A1 (https=)
SG (1) SG11201911826VA (https=)
TW (1) TWI818910B (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
CN100410249C (zh) 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物
SA112330992B1 (ar) 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
WO2016148066A1 (ja) * 2015-03-13 2016-09-22 杏林製薬株式会社 呼吸器感染症治療剤
EP3305294A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE

Also Published As

Publication number Publication date
KR20200016960A (ko) 2020-02-17
TW201906607A (zh) 2019-02-16
IL270831A (en) 2020-01-30
PH12019502835A1 (en) 2020-10-05
JP6671532B2 (ja) 2020-03-25
JP2020079330A (ja) 2020-05-28
AU2018283234A1 (en) 2019-12-12
MX2019014931A (es) 2020-02-13
US20210137913A1 (en) 2021-05-13
CL2019003630A1 (es) 2020-07-10
JP2020015769A (ja) 2020-01-30
EP3639826A4 (en) 2021-03-03
CN110891571A (zh) 2020-03-17
JPWO2018230686A1 (ja) 2019-12-12
JP6618660B2 (ja) 2019-12-11
EP3639826A1 (en) 2020-04-22
TWI818910B (zh) 2023-10-21
JP7098671B2 (ja) 2022-07-11
SG11201911826VA (en) 2020-01-30
BR112019025960A2 (pt) 2020-11-03

Similar Documents

Publication Publication Date Title
US20210228589A1 (en) Use of aerosolized levofloxacin for treating cystic fibrosis
JP2015521617A5 (https=)
CN102711760A (zh) 雾化抗生素用于治疗慢性阻塞性肺病的用途
WO2023207398A1 (zh) 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用
JP6618660B2 (ja) 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤
JP6077725B1 (ja) 呼吸器感染症治療剤
HK40026671A (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
CN121466090A (zh) 吸入性肺炎、肺化脓或肺脓肿的治疗剂
HK40098387A (zh) 吸入性肺炎、肺化脓或肺脓肿的治疗剂
HK40067557B (zh) 呼吸器官感染治疗剂
CN114732808B (zh) 牛磺酸在制备预防和治疗耐药结核病药物中的应用
JP2017137289A5 (https=)
AU2015275224B2 (en) Use of aerosolized levofloxacin for treating cystic fibrosis
CN118946357A (zh) 呼吸系统疾病治疗剂
WO2024114572A1 (zh) 化合物在制备治疗或预防结核分枝杆菌感染的药物中的应用
CN106890167A (zh) 一种具有抗结核活性的化合物及其应用
HK1168786B (en) Use of aerosolized levofloxacin for treating cystic fibrosis

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20231215